Vincenzo Casolaro of the University of Maryland School of Medicine in the United States will test the ability of a novel synthetic peptide, AT1002, to induce the pathways within the mucosa to increase the delivery of antigens. If successful, this peptide could be used as an adjuvant to increase vaccine effectiveness and lower the costs of delivering vaccines.
Grant ID
OPP1015126
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False